A 38-year-old woman, gravida 2, para 1, at 24 weeks' gestation comes to the physician for a routine prenatal evaluation. She has no history of major medical illness and takes no medications. Fetal ultrasonography shows a cardiac defect resulting from abnormal development of the endocardial cushions. This defect is most likely to result in which of the following?
Q72
A 28-year-old woman comes to the physician because she had a positive pregnancy test at home. She reports feeling nauseated and has vomited several times over the past week. During this period, she has also had increased urinary frequency. She is sexually active with her boyfriend and they use condoms inconsistently. Her last menstrual period was 5 weeks ago. Physical examination shows no abnormalities. A urine pregnancy test is positive. A pap smear is positive for a high-grade squamous intraepithelial lesion. Colposcopy shows cervical intraepithelial neoplasia grade II and III. Which of the following is the most appropriate next step in the management of this patient?
Q73
A 28-year-old woman presents with an abnormal vaginal discharge for the past week. She maintains a monogamous relationship but denies the use of barrier protection with her partner. She is 5 weeks late for her menstrual cycle. Subsequent testing demonstrates a positive pregnancy test. A wet mount demonstrates motile, pear-shaped organisms. Which of the following is the most appropriate treatment for this patient?
Q74
A 23-year-old woman gravida 2, para 1 at 12 weeks' gestation comes to the physician for her initial prenatal visit. She feels well. She was treated for genital herpes one year ago and gonorrhea 3 months ago. Medications include folic acid and a multivitamin. Vital signs are within normal limits. Pelvic examination shows a uterus consistent in size with a 12-week gestation. Urine dipstick is positive for leukocyte esterase and nitrite. Urine culture shows E. coli (> 100,000 colony forming units/mL). Which of the following is the most appropriate next step in management?
Q75
A 29-year-old woman presents to a medical office complaining of fatigue, nausea, and vomiting for 1 week. Recently, the smell of certain foods makes her nauseous. Her symptoms are more pronounced in the mornings. The emesis is clear-to-yellow without blood. She has had no recent travel out of the country. The medical history is significant for peptic ulcer, for which she takes pantoprazole. The blood pressure is 100/60 mm Hg, the pulse is 70/min, and the respiratory rate is 12/min. The physical examination reveals pale mucosa and conjunctiva, and bilateral breast tenderness. The LMP was 9 weeks ago. What is the most appropriate next step in the management of this patient?
Q76
A 16-year-old girl comes to the physician with her mother because of intermittent abdominal cramps, fatigue, and increased urination over the past 3 months. She has no history of serious illness. She reports that she has not yet had her first menstrual period. Her mother states that she receives mostly A and B grades in school and is very active in school athletics. Her mother has type 2 diabetes mellitus and her maternal aunt has polycystic ovary syndrome. Her only medication is a daily multivitamin. The patient is 150 cm (4 ft 11 in) tall and weighs 50 kg (110 lb); BMI is 22.2 kg/m2. Vital signs are within normal limits. A grade 2/6 early systolic murmur is heard best over the pulmonic area and increases with inspiration. The abdomen is diffusely tender to palpation and a firm mass is felt in the lower abdomen. Breast and pubic hair development are at Tanner stage 5. Which of the following is the most appropriate next step in management?
Q77
A 29-year-old woman, gravida 2, para 1, at 10 weeks' gestation comes to the physician for a prenatal visit. Over the past two weeks, she has felt nauseous in the morning and has had vulvar pruritus and dysuria that started 5 days ago. Her first child was delivered by lower segment transverse cesarean section because of macrosomia from gestational diabetes. Her gestational diabetes resolved after the child was born. She appears well. Ultrasound confirms fetal heart tones and an intrauterine pregnancy. Speculum exam shows a whitish chunky discharge. Her vaginal pH is 4.2. A wet mount is performed and microscopic examination is shown. Which of the following is the most appropriate treatment?
Q78
A 34-year-old woman, gravida 3, para 2, at 16 weeks' gestation comes to the physician because of nausea and recurrent burning epigastric discomfort for 1 month. Her symptoms are worse after heavy meals. She does not smoke or drink alcohol. Examination shows a uterus consistent in size with a 16-week gestation. Palpation of the abdomen elicits mild epigastric tenderness. The physician prescribes her medication to alleviate her symptoms. Treatment with which of the following drugs should be avoided in this patient?
Q79
A 27-year-old female in her 20th week of pregnancy presents for a routine fetal ultrasound screening. An abnormality of the right fetal kidney is detected. It is determined that the right ureteropelvic junction has failed to recanalize. Which of the following findings is most likely to be seen on fetal ultrasound:
Q80
A 23-year-old nulligravida presents for evaluation 5 weeks after her last menstrual period. Her previous menstruation cycle was regular, and her medical history is benign. She is sexually active with one partner and does not use contraception. A urine dipstick pregnancy test is negative. The vital signs are as follows: blood pressure 120/80 mm Hg, heart rate 71/min, respiratory rate 13/min, and temperature 36.8°C (98.2°F). The physical examination is notable for breast engorgement, increased pigmentation of the nipples, and linea nigra. The gynecologic examination demonstrates cervical and vaginal cyanosis.
Measurement of which of the following substances is most appropriate in this case?
Prenatal Care US Medical PG Practice Questions and MCQs
Question 71: A 38-year-old woman, gravida 2, para 1, at 24 weeks' gestation comes to the physician for a routine prenatal evaluation. She has no history of major medical illness and takes no medications. Fetal ultrasonography shows a cardiac defect resulting from abnormal development of the endocardial cushions. This defect is most likely to result in which of the following?
A. Transposition of the great vessels
B. Atrioventricular septal defect (Correct Answer)
C. Dextrocardia
D. Patent foramen ovale
E. Sinus venosus defect
Explanation: ***Atrioventricular septal defect***
- **Endocardial cushion defects** are a hallmark of atrioventricular septal defects, leading to a common atrioventricular valve and an interatrial and/or interventricular communication.
- This defect commonly presents in individuals with **Down syndrome (Trisomy 21)**, though it can occur in isolation.
*Transposition of the great vessels*
- This defect results from abnormal **spiraling of the conotruncal septum**, not from endocardial cushion malformation.
- It leads to the **aorta arising from the right ventricle** and the **pulmonary artery from the left ventricle**, a circulation incompatible with life without a shunt.
*Dextrocardia*
- **Dextrocardia** is a condition where the heart is located on the right side of the chest, usually due to abnormal embryonic folding, and is not directly caused by endocardial cushion defects.
- It can occur as an isolated finding or as part of a more complex syndrome like **Kartagener syndrome**.
*Patent foramen ovale*
- A **patent foramen ovale** is a common remnant of fetal circulation, occurring when the foramen ovale fails to close after birth.
- It is a defect of the **atrial septum secondary to incomplete fusion between the septum primum and septum secundum**, not an endocardial cushion defect.
*Sinus venosus defect*
- A **sinus venosus defect** is a type of atrial septal defect occurring near the entrance of the superior or inferior vena cava.
- It is caused by **abnormal development of the sinus venosus** and is not directly related to endocardial cushion malformation.
Question 72: A 28-year-old woman comes to the physician because she had a positive pregnancy test at home. She reports feeling nauseated and has vomited several times over the past week. During this period, she has also had increased urinary frequency. She is sexually active with her boyfriend and they use condoms inconsistently. Her last menstrual period was 5 weeks ago. Physical examination shows no abnormalities. A urine pregnancy test is positive. A pap smear is positive for a high-grade squamous intraepithelial lesion. Colposcopy shows cervical intraepithelial neoplasia grade II and III. Which of the following is the most appropriate next step in the management of this patient?
A. Perform loop electrosurgical excision
B. Diagnostic excisional procedure
C. Colposcopy and cytology at 6-month intervals for 12 months
D. Reevaluation with cytology and colposcopy 6 weeks after birth (Correct Answer)
E. Endocervical curettage
Explanation: ***Reevaluation with cytology and colposcopy 6 weeks after birth***
- Pregnancy is a state of relative **immunosuppression**, allowing high-grade lesions (CIN II/III) to potentially regress postpartum.
- **Invasive procedures** should be delayed until after delivery to avoid obstetric complications unless invasion is suspected.
*Perform loop electrosurgical excision*
- This procedure, while effective for CIN II/III, is generally **avoided during pregnancy** due to increased risks of hemorrhage, infection, and preterm labor.
- **Observation** is preferred in pregnant patients with CIN II/III, given the possibility of lesion regression postpartum.
*Diagnostic excisional procedure*
- Like LEEP, diagnostic excisional procedures (e.g., **cone biopsy**) carry significant risks during pregnancy, including **miscarriage** and **cervical incompetence**.
- It is usually reserved for cases where **invasive cancer** cannot be excluded by colposcopy and directed biopsies alone.
*Colposcopy and cytology at 6-month intervals for 12 months*
- While follow-up is appropriate, waiting 6 months for the initial follow-up is **too long** given the patient's pregnant status.
- The standard approach is to reevaluate postpartum, as pregnancy-related changes can affect lesion appearance and natural history.
*Endocervical curettage*
- **Endocervical curettage (ECC)** is **contraindicated in pregnancy** as it can disrupt the pregnancy and lead to complications.
- It is performed in non-pregnant patients to evaluate for disease extending into the endocervical canal.
Question 73: A 28-year-old woman presents with an abnormal vaginal discharge for the past week. She maintains a monogamous relationship but denies the use of barrier protection with her partner. She is 5 weeks late for her menstrual cycle. Subsequent testing demonstrates a positive pregnancy test. A wet mount demonstrates motile, pear-shaped organisms. Which of the following is the most appropriate treatment for this patient?
A. Metronidazole (Correct Answer)
B. Ceftriaxone
C. Tinidazole
D. Azithromycin
E. Fluconazole
Explanation: ***Metronidazole***
- The presence of **motile, pear-shaped organisms** on a wet mount is characteristic of **Trichomonas vaginalis infection**, which is treated effectively with metronidazole.
- While metronidazole is generally avoided early in pregnancy, the benefits often outweigh the risks for symptomatic trichomoniasis, especially since the patient is already 5 weeks late for her period and a positive pregnancy test has been confirmed.
*Ceftriaxone*
- This antibiotic is primarily used to treat **gonorrhea**, a sexually transmitted infection that presents with purulent discharge but does not typically show motile, pear-shaped organisms on wet mount.
- It is not effective against *Trichomonas vaginalis*.
*Tinidazole*
- Tinidazole is another effective drug against *Trichomonas vaginalis*, similar to metronidazole. However, **metronidazole is generally preferred as the first-line treatment**, especially in pregnancy, due to more extensive safety data and established guidelines.
- Although it could be used for trichomoniasis, metronidazole is typically the more immediate and widely recommended choice.
*Azithromycin*
- Azithromycin is the treatment of choice for **Chlamydia trachomatis infection**, which causes a different type of vaginal discharge and does not involve motile, pear-shaped organisms.
- It has no activity against *Trichomonas vaginalis*.
*Fluconazole*
- This antifungal medication is used to treat **vulvovaginal candidiasis (yeast infection)**, which presents with a thick, white, "cottage cheese-like" discharge and spores/hyphae on microscopy, not motile protozoa.
- It is ineffective against *Trichomonas vaginalis*.
Question 74: A 23-year-old woman gravida 2, para 1 at 12 weeks' gestation comes to the physician for her initial prenatal visit. She feels well. She was treated for genital herpes one year ago and gonorrhea 3 months ago. Medications include folic acid and a multivitamin. Vital signs are within normal limits. Pelvic examination shows a uterus consistent in size with a 12-week gestation. Urine dipstick is positive for leukocyte esterase and nitrite. Urine culture shows E. coli (> 100,000 colony forming units/mL). Which of the following is the most appropriate next step in management?
A. Perform cystoscopy
B. Administer gentamicin
C. Administer trimethoprim/sulfamethoxazole (TMP/SMX)
D. Administer amoxicillin/clavulanate (Correct Answer)
E. Perform renal ultrasound
Explanation: ***Administer amoxicillin/clavulanate***
- The patient has **asymptomatic bacteriuria** based on a positive urine dipstick for leukocyte esterase and nitrite and a urine culture showing *E. coli* (> 100,000 CFU/mL) in a pregnant patient.
- **Amoxicillin/clavulanate** is a safe and effective first-line antibiotic for treating asymptomatic bacteriuria in pregnancy due to its broad spectrum and safety profile for the fetus.
*Perform cystoscopy*
- **Cystoscopy** is an invasive procedure typically reserved for evaluating persistent hematuria, recurrent UTIs despite appropriate therapy, or suspected bladder pathology.
- It is not indicated for initial management of asymptomatic bacteriuria, especially in pregnancy, as it carries risks and offers no immediate therapeutic benefit for this condition.
*Administer gentamicin*
- **Gentamicin** is an aminoglycoside antibiotic that is generally **contraindicated in pregnancy** due to potential **fetal ototoxicity** and nephrotoxicity.
- While effective against *E. coli*, its risks outweigh the benefits for asymptomatic bacteriuria, especially when safer alternatives are available.
*Administer trimethoprim/sulfamethoxazole (TMP/SMX)*
- **Trimethoprim/sulfamethoxazole (TMP/SMX)** is generally **avoided in the first trimester** of pregnancy due to concerns about **folate antagonism** (trimethoprim) and potential teratogenic effects, such as neural tube defects, particularly between 6-12 weeks' gestation.
- The patient is at 12 weeks' gestation, making TMP/SMX a less safe choice compared to other antibiotics.
*Perform renal ultrasound*
- A **renal ultrasound** is typically performed if there are complications such as **pyelonephritis**, recurrent urinary tract infections, or suspicion of **structural abnormalities** in the urinary tract.
- For asymptomatic bacteriuria, an ultrasound is not part of the initial management unless there are specific indications or if the infection does not resolve with appropriate antibiotic therapy.
Question 75: A 29-year-old woman presents to a medical office complaining of fatigue, nausea, and vomiting for 1 week. Recently, the smell of certain foods makes her nauseous. Her symptoms are more pronounced in the mornings. The emesis is clear-to-yellow without blood. She has had no recent travel out of the country. The medical history is significant for peptic ulcer, for which she takes pantoprazole. The blood pressure is 100/60 mm Hg, the pulse is 70/min, and the respiratory rate is 12/min. The physical examination reveals pale mucosa and conjunctiva, and bilateral breast tenderness. The LMP was 9 weeks ago. What is the most appropriate next step in the management of this patient?
A. Beta-HCG levels and a transvaginal ultrasound (Correct Answer)
B. Beta-HCG levels and a transabdominal ultrasound
C. Beta-HCG levels and a pelvic CT
D. Abdominal x-ray
E. Abdominal CT with contrast
Explanation: ***Beta-HCG levels and a transvaginal ultrasound***
- The patient's symptoms (fatigue, nausea, vomiting, morning sickness, breast tenderness, and **amenorrhea** for 9 weeks) strongly suggest **early pregnancy**.
- **Urine or serum beta-HCG** confirms pregnancy, and a **transvaginal ultrasound** is crucial for confirming an **intrauterine pregnancy**, estimating gestational age, and ruling out complications like ectopic pregnancy, especially at this early stage when transabdominal ultrasound might not provide clear images.
*Beta-HCG levels and a transabdominal ultrasound*
- While beta-HCG levels are appropriate, a **transabdominal ultrasound** may not be sufficient to visualize an early intrauterine pregnancy at 9 weeks due to limited resolution compared to transvaginal ultrasound.
- A definitive confirmation of **intrauterine pregnancy** is critical to rule out an **ectopic pregnancy**, which is better achieved with transvaginal imaging in early gestation.
*Beta-HCG levels and a pelvic CT*
- **CT scans** expose the patient to significant **ionizing radiation**, which is **contraindicated in pregnancy** unless absolutely necessary for life-threatening conditions.
- While it could identify some pelvic pathologies, it is **not the primary imaging modality** for confirming or evaluating early pregnancy due to radiation risks and inferior soft tissue resolution for early gestational sacs compared to ultrasound.
*Abdominal x-ray*
- An **abdominal X-ray** involves **ionizing radiation** and offers very limited diagnostic value for early pregnancy, as it cannot visualize the gestational sac, fetus, or fetal heart activity.
- It is **contraindicated** in suspected pregnancy due to the risk of fetal harm.
*Abdominal CT with contrast*
- **Abdominal CT with contrast** involves both **ionizing radiation** and **contrast agents**, both of which pose significant risks to a developing fetus.
- It is an **inappropriate initial step** for suspected pregnancy and offers no specific diagnostic benefits for confirming or characterizing early gestation.
Question 76: A 16-year-old girl comes to the physician with her mother because of intermittent abdominal cramps, fatigue, and increased urination over the past 3 months. She has no history of serious illness. She reports that she has not yet had her first menstrual period. Her mother states that she receives mostly A and B grades in school and is very active in school athletics. Her mother has type 2 diabetes mellitus and her maternal aunt has polycystic ovary syndrome. Her only medication is a daily multivitamin. The patient is 150 cm (4 ft 11 in) tall and weighs 50 kg (110 lb); BMI is 22.2 kg/m2. Vital signs are within normal limits. A grade 2/6 early systolic murmur is heard best over the pulmonic area and increases with inspiration. The abdomen is diffusely tender to palpation and a firm mass is felt in the lower abdomen. Breast and pubic hair development are at Tanner stage 5. Which of the following is the most appropriate next step in management?
A. Pelvic ultrasound (Correct Answer)
B. Karyotyping
C. Serum β-hCG
D. Fasting glucose and lipid panel
E. Serum fT4
Explanation: ***Pelvic ultrasound***
- A **firm mass** in the **lower abdomen** of a 16-year-old with primary amenorrhea and a family history concerning for genetic predispositions (type 2 diabetes, PCOS) warrants imaging to evaluate for structural abnormalities.
- A pelvic ultrasound is the **first-line imaging modality** to assess the uterus, ovaries, and other pelvic organs, and to further characterize the palpable mass.
*Karyotyping*
- While **primary amenorrhea** can be caused by chromosomal abnormalities (e.g., Turner syndrome), a palpable abdominal mass points toward an **anatomical issue** over a genetic one.
- Karyotyping would be more appropriate if initial imaging was normal or if there were other features suggestive of a specific genetic syndrome, such as short stature or webbed neck.
*Serum β-hCG*
- Although abdominal cramps and a mass can occur in pregnancy, the patient reports **primary amenorrhea** (never had a period), making pregnancy less likely, especially with no stated sexual activity although it could exist.
- While a **beta-hCG** is often part of a workup for abdominal pain in reproductive-age females, the primary amenorrhea and a firm, palpable mass in this context make structural evaluation more urgent.
*Fasting glucose and lipid panel*
- The family history of type 2 diabetes and PCOS might suggest metabolic screening, but these investigations are not directly related to evaluating the **acute complaint of a palpable abdominal mass** and primary amenorrhea.
- These tests would be more appropriate for ongoing management or if polycystic ovary syndrome (PCOS) was being specifically investigated after excluding structural causes of amenorrhea.
*Serum fT4*
- **Thyroid hormone imbalances** can cause menstrual irregularities, but typically present as secondary amenorrhea (cessation of periods), not primary amenorrhea with a distinct abdominal mass.
- **Hypothyroidism** can lead to delayed puberty and menstrual irregularities, but it would not explain a palpable abdominal mass.
Question 77: A 29-year-old woman, gravida 2, para 1, at 10 weeks' gestation comes to the physician for a prenatal visit. Over the past two weeks, she has felt nauseous in the morning and has had vulvar pruritus and dysuria that started 5 days ago. Her first child was delivered by lower segment transverse cesarean section because of macrosomia from gestational diabetes. Her gestational diabetes resolved after the child was born. She appears well. Ultrasound confirms fetal heart tones and an intrauterine pregnancy. Speculum exam shows a whitish chunky discharge. Her vaginal pH is 4.2. A wet mount is performed and microscopic examination is shown. Which of the following is the most appropriate treatment?
A. Topical nystatin
B. Oral fluconazole
C. Intravaginal clotrimazole (Correct Answer)
D. Oral metronidazole
E. Intravaginal treatment with lactobacillus
Explanation: ***Intravaginal clotrimazole***
- The patient's symptoms of **vulvar pruritus**, **dysuria**, **whitish chunky discharge**, a **vaginal pH of 4.2**, and microscopy consistent with **yeast buds and hyphae** are highly suggestive of **vulvovaginal candidiasis (VVC)**.
- **Intravaginal azole antifungals** like clotrimazole are the **first-line treatment for VVC in pregnancy** due to their local action and minimal systemic absorption, making them safe for the fetus.
*Topical nystatin*
- While **nystatin** is an antifungal used for candidiasis, its **efficacy for vulvovaginal candidiasis is lower** compared to azoles.
- **Topical nystatin** is generally **not the preferred first-line treatment** for VVC, especially when more effective alternatives like azoles are available.
*Oral fluconazole*
- **Oral fluconazole** is generally **avoided in the first trimester of pregnancy** due to potential risks of **teratogenicity**, including an increased risk of miscarriage and congenital malformations at higher doses, though lower single doses are considered by some to be low risk.
- Given the patient is at **10 weeks' gestation**, topical treatment is preferred over oral options to minimize systemic exposure.
*Oral metronidazole*
- **Metronidazole** is an **antibiotic and antiprotozoal** medication primarily used to treat **bacterial vaginosis** or **trichomoniasis**, conditions that do not match the patient's presentation.
- The patient's **vaginal pH of 4.2** and **chunky discharge** differentiate VVC from bacterial vaginosis (which typically has a pH >4.5 and thin, malodorous discharge) or trichomoniasis (often frothy discharge and high pH).
*Intravaginal treatment with lactobacillus*
- **Lactobacillus** is used to help restore the normal vaginal flora, often as an **adjunctive treatment** or for prophylaxis, particularly in cases of **recurrent bacterial vaginosis** or after antibiotic therapy.
- It is **not a primary treatment for active fungal infections** like vulvovaginal candidiasis, as it does not directly eradicate the yeast.
Question 78: A 34-year-old woman, gravida 3, para 2, at 16 weeks' gestation comes to the physician because of nausea and recurrent burning epigastric discomfort for 1 month. Her symptoms are worse after heavy meals. She does not smoke or drink alcohol. Examination shows a uterus consistent in size with a 16-week gestation. Palpation of the abdomen elicits mild epigastric tenderness. The physician prescribes her medication to alleviate her symptoms. Treatment with which of the following drugs should be avoided in this patient?
A. Magnesium hydroxide
B. Sucralfate
C. Pantoprazole
D. Cimetidine
E. Misoprostol (Correct Answer)
Explanation: ***Misoprostol***
- **Misoprostol** is a prostaglandin E1 analog that stimulates uterine contractions, which can lead to **miscarriage** or **preterm labor**.
- Its **abortifacient properties** contraindicate its use in pregnancy, particularly for symptoms like heartburn.
*Magnesium hydroxide*
- **Magnesium hydroxide** is a common **antacid** that is generally considered safe for occasional use during pregnancy to relieve heartburn.
- While excessive doses can lead to **diarrhea**, it is not contraindicated and does not pose a direct threat to fetal development or pregnancy maintenance.
*Sucralfate*
- **Sucralfate** forms a protective barrier over ulcers and erosions in the GI tract and is minimally absorbed systemically, making it a safe option in pregnancy.
- It works locally and has no known teratogenic effects, often used for **gastric protection** during gestation.
*Pantoprazole*
- **Pantoprazole** is a **proton pump inhibitor (PPI)** that reduces stomach acid production and is generally considered safe for use in pregnancy when indicated for GERD or severe heartburn.
- It is classified as pregnancy category B or C, but extensive observational data have not shown an increased risk of malformations.
*Cimetidine*
- **Cimetidine** is an **H2 receptor antagonist** that decreases gastric acid secretion and is generally considered safe for use in pregnancy to treat heartburn or GERD.
- It is classified as pregnancy category B, and its use is well-established with no significant adverse fetal outcomes reported.
Question 79: A 27-year-old female in her 20th week of pregnancy presents for a routine fetal ultrasound screening. An abnormality of the right fetal kidney is detected. It is determined that the right ureteropelvic junction has failed to recanalize. Which of the following findings is most likely to be seen on fetal ultrasound:
A. Renal cysts
B. Duplicated ureter
C. Bilateral renal agenesis
D. Pelvic kidney
E. Unilateral hydronephrosis (Correct Answer)
Explanation: ***Unilateral hydronephrosis***
- Failure of the **ureteropelvic junction (UPJ)** to recanalize leads to an obstruction of urine flow from the **renal pelvis** into the ureter.
- This obstruction causes a buildup of urine in the renal pelvis and calyces, a condition known as **hydronephrosis**, which will be unilateral as only the right kidney is affected.
*Renal cysts*
- **Renal cysts** are typically associated with conditions like polycystic kidney disease or multicystic dysplastic kidney, which involve abnormal development of renal parenchyma, not specifically a UPJ obstruction.
- While hydronephrosis can sometimes lead to cystic changes if severe and prolonged, in the initial stages of a UPJ obstruction detected on fetal ultrasound, **hydronephrosis** itself is the primary and most likely finding.
*Duplicated ureter*
- A **duplicated ureter** is a distinct congenital anomaly involving the formation of two ureters draining a single kidney or separate renal moieties.
- It does not directly result from the failure of **ureteropelvic junction recanalization**.
*Bilateral renal agenesis*
- **Bilateral renal agenesis** means both kidneys failed to develop, which would lead to severe oligohydramnios and is incompatible with sustained fetal life.
- The question describes an abnormality only in the **right kidney**, making bilateral agenesis incorrect.
*Pelvic kidney*
- A **pelvic kidney** (renal ectopia) occurs when the kidney fails to ascend from the pelvis to its normal lumbar position.
- This is a positional anomaly and is not directly caused by a failure of **ureteropelvic junction recanalization**.
Question 80: A 23-year-old nulligravida presents for evaluation 5 weeks after her last menstrual period. Her previous menstruation cycle was regular, and her medical history is benign. She is sexually active with one partner and does not use contraception. A urine dipstick pregnancy test is negative. The vital signs are as follows: blood pressure 120/80 mm Hg, heart rate 71/min, respiratory rate 13/min, and temperature 36.8°C (98.2°F). The physical examination is notable for breast engorgement, increased pigmentation of the nipples, and linea nigra. The gynecologic examination demonstrates cervical and vaginal cyanosis.
Measurement of which of the following substances is most appropriate in this case?
A. Blood estriol
B. Blood human chorionic gonadotropin (Correct Answer)
C. Urinary estrogen metabolites
D. Urinary human chorionic gonadotropin
E. Blood progesterone
Explanation: ***Blood human chorionic gonadotropin***
- The patient exhibits classic signs of early pregnancy, including **breast engorgement**, **nipple hyperpigmentation**, **linea nigra**, and **cervical and vaginal cyanosis** (Chadwick's sign). These signs, combined with a missed menstrual period and unprotected intercourse, strongly indicate pregnancy despite the negative urine dipstick.
- A **blood human chorionic gonadotropin (hCG)** test is more sensitive than a urine test, detecting lower levels of hCG earlier in pregnancy, and is therefore the most appropriate next step to confirm pregnancy.
*Blood estriol*
- **Estriol** levels are used to assess fetal well-being in the late second and third trimesters, typically as part of the **triple or quadruple screen**, not for early pregnancy detection.
- Its levels become significantly elevated much later in pregnancy, making it unsuitable for confirming a pregnancy at 5 weeks.
*Urinary estrogen metabolites*
- **Urinary estrogen metabolites** are primarily used to assess ovarian function and fertility, or to monitor hormone replacement therapy.
- They are not a reliable or standard method for the early detection or confirmation of pregnancy.
*Urinary human chorionic gonadotropin*
- While **urinary hCG** is used for pregnancy detection (e.g., home pregnancy tests), a negative result at 5 weeks, especially in the presence of strong clinical signs of pregnancy, suggests that the levels might be below the detection threshold of the urine test.
- A **quantitative blood hCG** test is superior in sensitivity and can detect very low levels of hCG, confirming or ruling out early pregnancy more definitively.
*Blood progesterone*
- **Progesterone** levels are necessary to maintain a pregnancy, but they do not confirm a pregnancy itself. High progesterone can indicate ovulation and potential luteal phase support.
- While useful for assessing the viability of a confirmed early pregnancy or diagnosing conditions like ectopic pregnancy, it's not the primary test to confirm the presence of pregnancy.